Ascendis Pharma A/S Equity
Ascendis Pharma A/S (ASND) had Equity of -EUR 162.82 million as of 2025-12-31, per its 20-F filed 2026-02-11.
Financial Statements › Notes
ifrs-full:Equity · last filed 2026-02-11
- 2025-12-31: Equity -162.82M EUR.
- 2025-09-30: Equity -174.07M EUR.
- 2025-06-30: Equity -187.57M EUR.
- 2025-03-31: Equity -189.81M EUR.
| Period end | Equity |
|---|---|
| 2025-12-31 | -162.82M EUR 20-F · filed 2026-02-11 |
| 2025-09-30 | -174.07M EUR 6-K · filed 2025-11-12 |
| 2025-06-30 | -187.57M EUR 6-K · filed 2025-08-07 |
| 2025-03-31 | -189.81M EUR 6-K · filed 2025-05-01 |
| 2024-12-31 | -105.71M EUR 20-F · filed 2026-02-11 |
| 2024-09-30 | -97.32M EUR 6-K · filed 2025-11-12 |
| 2024-06-30 | -321.13M EUR 6-K · filed 2025-08-07 |
| 2024-03-31 | -238.18M EUR 6-K · filed 2025-05-01 |
| 2023-12-31 | -145.70M EUR 20-F · filed 2026-02-11 |
| 2023-09-30 | -73.43M EUR 6-K · filed 2024-11-14 |
| 2023-06-30 | 64.84M EUR 6-K · filed 2024-09-03 |
| 2023-03-31 | 167.20M EUR 6-K · filed 2024-05-02 |
| 2023-01-01 | 263.35M EUR 20-F · filed 2025-02-12 |
| 2022-12-31 | 263.35M EUR 20-F · filed 2026-02-11 |
| 2022-09-30 | 451.55M EUR 6-K · filed 2023-11-07 |
| 2022-06-30 | 607.84M EUR 6-K · filed 2023-09-05 |
| 2022-03-31 | 672.82M EUR 6-K · filed 2023-04-27 |
| 2021-12-31 | 883.63M EUR 20-F · filed 2025-02-12 |
| 2021-09-30 | 993.56M EUR 6-K · filed 2022-11-02 |
| 2021-06-30 | 687.49M EUR 6-K · filed 2022-08-10 |
| 2021-03-31 | 802.82M EUR 6-K · filed 2022-05-11 |
| 2020-12-31 | 838.71M EUR 20-F · filed 2024-02-07 |
| 2020-09-30 | 951.59M EUR 6-K · filed 2021-11-10 |
| 2020-06-30 | 477.14M EUR 6-K · filed 2021-08-27 |
| 2020-03-31 | 548.83M EUR 6-K · filed 2021-05-27 |
| 2019-12-31 | 597.11M EUR 20-F · filed 2023-02-16 |
| 2019-09-30 | 660.92M EUR 6-K · filed 2020-11-12 |
| 2019-06-30 | 675.08M EUR 6-K · filed 2020-08-27 |
| 2019-03-31 | 716.66M EUR 6-K · filed 2020-05-19 |
| 2018-12-31 | 280.05M EUR 20-F · filed 2022-03-02 |
| 2018-09-30 | 304.20M EUR 6-K · filed 2019-11-18 |
| 2018-06-30 | 332.23M EUR 6-K · filed 2019-08-28 |
| 2018-03-31 | 347.41M EUR 6-K · filed 2019-05-30 |
| 2017-12-31 | 187.21M EUR 20-F · filed 2021-03-10 |
| 2017-09-30 | 202.15M EUR 6-K · filed 2018-11-28 |
| 2017-06-30 | 126.47M EUR 6-K · filed 2018-08-29 |
| 2017-03-31 | 154.83M EUR 6-K · filed 2018-05-30 |
| 2016-12-31 | 176.61M EUR 20-F · filed 2020-04-03 |
| 2015-12-31 | 120.33M EUR 20-F · filed 2019-04-03 |
| 2014-12-31 | 45.81M EUR 20-F · filed 2018-03-28 |